Metraipolis › archive › dc_4e4f60adfb96

[Long-term outcomes of first-line iFCR regimen in chronic lymphocytic leukemia/small lymphocytic lymphoma and the role of MRD] — Europe PMC PMID:42161660

Source
Europe PMC (chi)
Original
https://europepmc.org/article/MED/42161660
DOI
10.3760/cma.j.cn121090-20251125-00549
License (as archived)
solo-consultazione
Archived
2026-11-03T12:33:23.430Z
SHA-256 of the archived text
b0c1e02c2814975cea964e74de00e2ffe409b9676570737acb2cb3a25ccb7def
Stable URL of this page
https://metraipolis.com/documento/dc_4e4f60adfb96

How to cite

[Long-term outcomes of first-line iFCR regimen in chronic lymphocytic leukemia/small lymphocytic lymphoma and the role of MRD] — Europe PMC PMID:42161660 — Europe PMC (chi), https://europepmc.org/article/MED/42161660 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4e4f60adfb96 (Metraipolis archive dc_4e4f60adfb96, sha256 b0c1e02c2814975cea964e74de00e2ffe409b9676570737acb2cb3a25ccb7def)
BibTeX
@misc{dc4e4f60adfb96,
  title = {[Long-term outcomes of first-line iFCR regimen in chronic lymphocytic leukemia/small lymphocytic lymphoma and the role of MRD] — Europe PMC PMID:42161660},
  howpublished = {Europe PMC (chi)},
  url = {https://europepmc.org/article/MED/42161660},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4e4f60adfb96; sha256 b0c1e02c2814975cea964e74de00e2ffe409b9676570737acb2cb3a25ccb7def},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42161660. Agents can read the archived copy with the MCP tool read_document.